VC Firm with a permanent, evergreen capital base investing in early-stage healthcare companies with line of sight to $1mm+ of ARR. They have a concentrated portfolio and a 20+ year track record of top-decile performance. Sopris prefers to be a first-check investor with the capacity to follow on.